Study reveals why stroke patients skip lifesaving pills

NCT ID NCT03153020

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study followed 633 stroke or TIA survivors in France to understand why some stop taking their secondary prevention medications. Researchers looked at factors like age, beliefs about medicine, and healthcare access. The goal is to improve long-term adherence and prevent future strokes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospices Civils de Lyon, Pôle Information Médicale Evaluation Recherche

    Lyon, 69423, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.